
|Articles|May 15, 2003
ICL effective treatment for moderate, high hyperopia
Author(s)Julia Talsma
San Francisco-At 1-year follow-up, the majority of patients who received the hyperopic Implantable Contact Lens (ICL, STAAR Surgical, Monrovia, CA) for correction of moderate to high hyperopia were satisfied with an uncorrected visual acuity (UCVA) of at least 20/40 or better, noted Paul J. Dougherty, MD, who spoke during the American Society of Cataract and Refractive Surgery Annual Meeting.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Laru-zova meets primary endpoint in pivotal VISTA trial for X-linked retinitis pigmentosa
2
EyeCon 2026: ODs and MDs pull up a chair
3
Addressing geographic variation in dry eye disease care requires patient-centric approaches
4
How screen time and eyelid health affect dry eye risk
5











